Literature DB >> 19921977

PCBaSe Sweden: a register-based resource for prostate cancer research.

Eva Hagel1, Hans Garmo, Anna Bill-Axelson, Ola Bratt, Jan-Erik Johansson, Jan Adolfsson, Mats Lambe, Pär Stattin.   

Abstract

Objective. To construct a database for clinical epidemiological prostate cancer research based on linkages between the National Prostate Cancer Register (NPCR) of Sweden, a population-based, nationwide quality database, and other nationwide registries. Material and methods. By use of the individually unique Swedish Personal Identity Number, the NPCR was linked to the Swedish Cancer Registry, the Cause of Death Register, the Prescribed Drug Register, the National Patient Register and the Acute Myocardial Infarction Register, all held at the Centre for Epidemiology at the National Board of Health and Welfare, and the Register of the Total Population, the Longitudinal Integration Database for Health Insurance and Labor Market Studies and the Multi-Generation Register, held at Statistics Sweden, and to the Swedish Hernia Register. Results. Record linkages between the NPCR and the Swedish Cancer Registry, the Cause of Death Register and the Register of the Total Population generated a database, named PCBaSe Sweden, including 80 079 prostate cancer cases, diagnosed between 1 January 1996 and 31 December 2006. Record linkage between PCBaSe Sweden and the Prescribed Drug Register generated 59 721 unique matches and linkage to the Acute Myocardial Infarction Register resulted in 11 459 matches. Conclusion. PCBaSe Sweden is a newly created and unique database with over 80 000 cases of prostate cancer with comprehensive data on inpatient and outpatient care, patterns of use of prescribed drugs and socioeconomic and familial factors. Many topics in clinical prostate cancer epidemiology can be investigated. using PCBaSe Sweden.

Entities:  

Mesh:

Year:  2009        PMID: 19921977     DOI: 10.3109/00365590903024577

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  19 in total

1.  Guidelines are too important to be left to clinical experts.

Authors:  Mattias Johansson; Pär Stattin
Journal:  CMAJ       Date:  2011-12-19       Impact factor: 8.262

2.  Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden.

Authors:  Mieke Van Hemelrijck; Jan Adolfsson; Hans Garmo; Anna Bill-Axelson; Ola Bratt; Erik Ingelsson; Mats Lambe; Pär Stattin; Lars Holmberg
Journal:  Lancet Oncol       Date:  2010-04-13       Impact factor: 41.316

3.  Risk of localized and advanced prostate cancer among immigrants versus native-born Swedish men: a nation-wide population-based study.

Authors:  Stacy Loeb; Linda Drevin; David Robinson; Erik Holmberg; Sigrid Carlsson; Mats Lambe; Pär Stattin
Journal:  Cancer Causes Control       Date:  2012-12-25       Impact factor: 2.506

4.  Anti-androgen prescribing patterns, patient treatment adherence and influencing factors; results from the nationwide PCBaSe Sweden.

Authors:  B Grundmark; H Garmo; B Zethelius; P Stattin; M Lambe; L Holmberg
Journal:  Eur J Clin Pharmacol       Date:  2012-05-05       Impact factor: 2.953

5.  Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort Study.

Authors:  David Robinson; Hans Garmo; Pär Stattin; Karl Michaëlsson
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

6.  Fathering of dizygotic twins and risk of prostate cancer: nationwide, population-based case-control study.

Authors:  Sara Wirén; Linda Drevin; Olof Akre; David Robinson; Pär Stattin
Journal:  PLoS One       Date:  2014-10-22       Impact factor: 3.240

7.  Use of 5α-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study.

Authors:  David Robinson; Hans Garmo; Anna Bill-Axelson; Lorelei Mucci; Lars Holmberg; Pär Stattin
Journal:  BMJ       Date:  2013-06-18

8.  Mortality following hip fracture in men with prostate cancer.

Authors:  Mieke Van Hemelrijck; Hans Garmo; Karl Michaëlsson; Andreas Thorstenson; Olof Akre; Pär Stattin; Lars Holmberg; Jan Adolfsson
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

9.  Fatherhood status and risk of prostate cancer: nationwide, population-based case-control study.

Authors:  Sara M Wirén; Linda I Drevin; Sigrid V Carlsson; Olof Akre; Erik C Holmberg; David E Robinson; Hans G Garmo; Pär E Stattin
Journal:  Int J Cancer       Date:  2013-03-08       Impact factor: 7.396

10.  Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes.

Authors:  Prasanna Sooriakumaran; Tommy Nyberg; Olof Akre; Leif Haendler; Inge Heus; Mats Olsson; Stefan Carlsson; Monique J Roobol; Gunnar Steineck; Peter Wiklund
Journal:  BMJ       Date:  2014-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.